Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.

Item

http://www.wikidata.org/entity/Q40139981

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.

@en

type

Item

label

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.

@en

prefLabel

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.

@en

P1476

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.

@en

P2093

Brendan Prideaux

http://www.w3.org/2001/XMLSchema#string

Chao Chen

http://www.w3.org/2001/XMLSchema#string

Firat Kaya

http://www.w3.org/2001/XMLSchema#string

Isaac Daudelin

http://www.w3.org/2001/XMLSchema#string

Jansy Sarathy

http://www.w3.org/2001/XMLSchema#string

Jillian Dietzold

http://www.w3.org/2001/XMLSchema#string

Jodi Lestner

http://www.w3.org/2001/XMLSchema#string

Matthew Zimmerman

http://www.w3.org/2001/XMLSchema#string

Padmini Salgame

http://www.w3.org/2001/XMLSchema#string

Paul O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis

In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania

High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.

Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

Population pharmacokinetics of ethambutol in South African tuberculosis patients.

Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children

The association between sterilizing activity and drug distribution into tuberculosis lesions.

P31

scholarly article

P356

10.1128/AAC.00924-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Isabela Dias-Freedman

Landry Blanc

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696241

http://www.w3.org/2001/XMLSchema#string

P932

5571334

http://www.w3.org/2001/XMLSchema#string